Teva Pharmaceuticals blocked generic competition for Copaxone, Baltimore mayor and council say in antitrust complaint
MLex Summary: Teva Pharmaceuticals is accused of blocking the entry of generic versions of its prescription drug Copaxone in an antitrust complaint filed by the mayor and City Council of Baltimore....To view the full article, register now.
Already a subscriber? Click here to view full article